Saw Palmetto and Beta-Sitosterol
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Saw Palmetto
The classic prostate supplement — large trials say mostly placebo, though some men report symptom relief.
Grade C1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Compound or practice
Beta-Sitosterol
A plant sterol with real evidence for prostate (BPH) urinary symptoms and cholesterol.
Grade B2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Saw Palmetto | Beta-Sitosterol |
|---|---|---|
| BPH urinary symptoms | Evidence grade CSmall effectmixedCAMUS null | Evidence grade BModerate effecthighCochrane-supported |
Graded only in Saw Palmetto
None — every outcome it grades is graded in both.
Graded only in Beta-Sitosterol
- LDL cholesterol Small effectEvidence grade B
Conditions
Only in Saw Palmetto
- Benign prostatic hyperplasia May improveEvidence grade C
Only in Beta-Sitosterol
None.
What each entry says about the other
- Beta-Sitosterol’s entry · Works together: Common BPH stack.
- Beta-Sitosterol’s entry · Goes with: Common BPH stack.
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.